Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1H-Indol-3-yl)-1H-imidazol-4-yl)(3,4,5-trimethoxyphenyl) Methanone (ABI-231) Analogues Targeting the Colchicine Binding Site in Tubulin.

Published on Jun 28, 2019in Journal of Medicinal Chemistry6.205
· DOI :10.2210/PDB6O61/PDB
Qinghui Wang9
Estimated H-index: 9
(UTHSC: University of Tennessee Health Science Center),
Kinsie E. Arnst7
Estimated H-index: 7
(UTHSC: University of Tennessee Health Science Center)
+ 5 AuthorsWei Li54
Estimated H-index: 54
(Sichuan University)
Sources
Abstract
ABI-231 is a potent, orally bioavailable tubulin inhibitor that interacts with the colchicine binding site and is currently undergoing clinical trials for prostate cancer. Guided by the crystal structure of ABI-231 in complex with tubulin, we performed structure–activity relationship studies around the 3-indole moiety that led to the discovery of several potent ABI-231 analogues, most notably 10ab and 10bb. The crystal structures of 10ab and 10bb in complex with tubulin confirmed their improved molecular interactions to the colchicine site. In vitro, biological studies showed that new ABI-231 analogues disrupt tubulin polymerization, promote microtubule fragmentation, and inhibit cancer cell migration. In vivo, analogue 10bb not only significantly inhibits primary tumor growth and decreases tumor metastasis in melanoma xenograft models but also shows a significant ability to overcome paclitaxel resistance in a taxane-resistant PC-3/TxR model. In addition, pharmacological screening suggested that 10bb has ...
📖 Papers frequently viewed together
8 Citations
9 Citations
20 Citations
References0
Newest
#1Vivek K. Kashyap (UTHSC: University of Tennessee Health Science Center)H-Index: 8
#2Qinghui Wang (UTHSC: University of Tennessee Health Science Center)H-Index: 9
Last. Subhash C. Chauhan (UTHSC: University of Tennessee Health Science Center)H-Index: 49
view all 13 authors...
The management of pancreatic cancer (PanCa) is exceptionally difficult due to poor response to available therapeutic modalities. Tubulins play a major role in cell dynamics, thus are important molecular targets for cancer therapy. Among various tubulins, βIII and βIV-tubulin isoforms have been primarily implicated in PanCa progression, metastasis and chemo-resistance. However, specific inhibitors of these isoforms that have potent anti-cancer activity with low toxicity are not readily available....
14 CitationsSource
#1Qinghui Wang (UTHSC: University of Tennessee Health Science Center)H-Index: 9
#2Kinsie E. Arnst (UTHSC: University of Tennessee Health Science Center)H-Index: 7
Last. Wei Li (Guangzhou Medical University)H-Index: 54
view all 11 authors...
Colchicine binding site inhibitors (CBSIs) hold great potential in developing new generations of antimitotic drugs. Unlike existing tubulin inhibitors such as paclitaxel, they are generally much less susceptible to resistance caused by the overexpression of drug efflux pumps. The 3,4,5-trimethoxyphenyl (TMP) moiety is a critical component present in many CBSIs, playing an important role in maintaining suitable molecular conformations of CBSIs and contributing to their high binding affinities to ...
21 CitationsSource
#1Souvik Banerjee (UTHSC: University of Tennessee Health Science Center)H-Index: 11
#2Kinsie E. Arnst (UTHSC: University of Tennessee Health Science Center)H-Index: 7
Last. Duane D. Miller (UTHSC: University of Tennessee Health Science Center)H-Index: 65
view all 11 authors...
We report the design, synthesis, and biological evaluation of heterocyclic-fused pyrimidines as tubulin polymerization inhibitors targeting the colchicine binding site with significantly improved therapeutic index. Additionally, for the first time, we report high-resolution X-ray crystal structures for the best compounds in this scaffold, 4a, 4b, 6a, and 8b. These structures not only confirm their direct binding to the colchicine site in tubulin and reveal their detailed molecular interactions b...
46 CitationsSource
#1Yuxi Wang (Sichuan University)H-Index: 18
#2Yamei Yu (Sichuan University)H-Index: 12
Last. Jinliang Yang (Sichuan University)H-Index: 22
view all 11 authors...
As a major component of the cytoskeleton, microtubules consist of αβ-tubulin heterodimers and have been recognized as attractive targets for cancer chemotherapy. Microtubule-stabilizing agents (MSAs) promote polymerization of tubulin and stabilize the polymer, preventing depolymerization. The molecular mechanisms by which MSAs stabilize microtubules remain elusive. Here we report a 2.05 A crystal structure of tubulin complexed with taccalonolide AJ, a newly identified taxane-site MSA. Taccalonol...
33 CitationsSource
#1Xiaoxin Wu (UTHSC: University of Tennessee Health Science Center)H-Index: 1
#2Qinghui Wang (UTHSC: University of Tennessee Health Science Center)H-Index: 9
Last. Wei LiH-Index: 54
view all 3 authors...
Microtubules are involved in many critical cellular processes including cell division, cell shape maintenance, vesicle transportation and motility regulation. Disruption of tubulin dynamics is a well-validated cancer drug target with several FDA approved, highly efficacious tubulin inhibitors targeting the taxane or the vinca binding sites. Despite the tremendous successes for these clinical tubulin inhibitors, their limitations are also apparent, particularly in the development of transporter m...
38 CitationsSource
#1Shelley McGuire (WSU: Washington State University)H-Index: 21
1,273 CitationsSource
#1Olexiy AseyevH-Index: 1
#2Joana RibeiroH-Index: 5
Last. Fatima CardosoH-Index: 77
view all 3 authors...
ABSTRACTIntroduction: Breast cancer is the second leading cause of cancer death among women and the median survival of metastatic breast cancer (MBC) has remained, for many decades, at two to three years after diagnosis. Eribulin mesylate is a nontaxane inhibitor of microtubule dynamics and the only cytotoxic agent in the last decade to improve overall survival in heavily pretreated patients with MBC. Eribulin was approved for the treatment of MBC in 2010 by the FDA in patients that received at ...
15 CitationsSource
#1Yuxi Wang (Sichuan University)H-Index: 18
#2Hang Zhang (Sichuan University)H-Index: 4
Last. Jinliang Yang (Sichuan University)H-Index: 22
view all 10 authors...
Microtubules are dynamic assemblies of αβ-tubulin heterodimers and have been recognized as highly attractive targets for cancer chemotherapy. A broad range of agents bind to tubulin and interfere with microtubule assembly. Despite having a long history of characterization, colchicine binding site inhibitors (CBSIs) have not yet reached the commercial phase as anti-cancer drugs to date. We determined the structures of tubulin complexed with a set of structurally diverse CBSIs (lexibulin, nocodazo...
105 CitationsSource
#1Matthew Trendowski (SU: Syracuse University)H-Index: 12
Through years of evolutionary selection pressures, organisms have developed potent toxins that coincidentally have marked antineoplastic activity. These natural products have been vital for the development of multiagent treatment regimens currently employed in cancer chemotherapy, and are used in the treatment of a variety of malignancies. Therefore, this review catalogs recent advances in natural product-based drug discovery via the examination of mechanisms of action and available clinical dat...
32 CitationsSource
#1Flora Zagouri (UoA: National and Kapodistrian University of Athens)H-Index: 29
Last. Aristotle Bamias (UoA: National and Kapodistrian University of Athens)H-Index: 34
view all 5 authors...
Ovarian cancer is the most lethal gynecologic malignancy; consequently, there is a need for effective therapies. Epothilones are microtubule-stabilizing agents that inhibit cell growth. Currently, patupilone and its four synthetic derivatives ixabepilone, BMS-310705, sagopilone, 20-desmethyl-20-methylsulfanyl epothilone B and epothilone D, as well as its derivative KOS-1584, are under clinical evaluation. This is the first systematic review conducted in accordance with the PRISMA (Preferred Repo...
8 CitationsSource
Cited By13
Newest
#1Arun Kanakkanthara (Mayo Clinic)H-Index: 12
#2John H. Miller (Victoria University of Wellington)H-Index: 47
Class III β-tubulin (βIII-tubulin) is frequently overexpressed in human tumors and is associated with resistance to microtubule-targeting agents, tumor aggressiveness, and poor patient outcome. Understanding the mechanisms regulating βIII-tubulin expression and the varied functions βIII-tubulin may have in different cancers is vital to assess the prognostic value of this protein and to develop strategies to enhance therapeutic benefits in βIII-tubulin overexpressing tumors. Here we gather all th...
Source
#1Shuai Lian (Changchun University of Science and Technology)
#2Xun Gao (Changchun University of Science and Technology)H-Index: 9
Last. Jingquan Lin (Changchun University of Science and Technology)H-Index: 15
view all 5 authors...
Abstract Fenbendazole, a benzimidazole derivative with anti-tubulin polymerization properties, has been widely used in the treatment of parasitic infections. Because of its anticancer activity similar to that of many anticancer drugs, low cost and few side effects, fenbendazole has attracted wide research attention. The chemical adsorption of fenbendazole and gold nanoparticles are studied by the UV-Vis spectrophotometry, density functional method, Raman spectroscopy and surface-enhanced Raman s...
Source
#1Da-Yun Luo (Yunnan University)H-Index: 3
#2Xing-Mei Hu (Yunnan University)H-Index: 2
Last. Sheng-Jiao Yan (Yunnan University)H-Index: 21
view all 5 authors...
ABSTRACT null null A novel method was developed for the construction of highly functionalized indole derivatives (3), including fluorinated indoles, via a site-selective, one-pot, two-step nucleophilic aromatic substitution reaction of o-difluorobenzene derivatives (1) with heterocyclic ketene aminals (HKAs) (2) promoted by two different bases (K2CO3 and Cs2CO3). A diverse library of indoles 3 was generated in good to excellent yields using a conventional base-mediated approach rather than metal...
Source
#1Pankaj Sharma (OSU: Ohio State University)H-Index: 9
view all 5 authors...
Nitrogen-containing heterocyclic rings are common structural components of marketed drugs. Among these heterocycles, imidazole/fused imidazole rings are present in a wide range of bioactive compounds. The unique properties of such structures, including high polarity and the ability to participate in hydrogen bonding and coordination chemistry, allow them to interact with a wide range of biomolecules, and imidazole-/fused imidazole-containing compounds are reported to have a broad spectrum of bio...
Source
#1Hairong Tang (Fudan University)H-Index: 1
#2Yuru Liang (CAS: Chinese Academy of Sciences)H-Index: 4
Last. Yang Wang (Fudan University)H-Index: 5
view all 5 authors...
Abstract Organoselenium compounds have attracted growing interests as promising antitumor agents over recent years. Herein, four series of novel selenium-containing chiral 1,4-diarylazetidin-2-ones were asymmetrically synthesized and biologically evaluated for antitumor activities. Among them, compound 7 was found to be about 10-fold more potent than its prototype compound 1, and compound 9a exhibited the most potent cytotoxicity against five human cancer cell lines, including a paclitaxel-resis...
1 CitationsSource
Metal complexes of [NiL2(NO3)2] (1), [CuL2(NO3)2] (2) and [ZnL2(NO3)2] (3) with the 1-trifluoroethoxyl-2,9,10-trimethoxy-7-oxoaporphine (L) ligand were synthesized. We discovered that complexes 1–3 exhibited considerable anticancer activity in vitro via simultaneously targeting microtubules and mitochondria. Complexes 1–3 impaired mitochondrial bioenergetic function by causing ATP depletion and mitochondrial membrane depolarization. They also triggered excessive generation of intracellular ROS a...
Source
#1Hanbing Ning (Zhengzhou University)H-Index: 2
#2Wenquan Lu (Zhengzhou University)
Last. Hongtao Wen (Zhengzhou University)H-Index: 2
view all 8 authors...
Coptis chinensis Franch. has been extensively used in traditional Chinese medicine. The chemical structure of oxyepiberberine, as an alkaloid isolated from Coptis chinensis Franch., has been previously studied. However, anti-cancer effects and underlying mechanisms of oxyepiberberine need to be explored. This study aimed to investigate the anti-cancer effects and underlying mechanisms of oxyepiberberine on LS-1034 human colon cancer cells. The anti-proliferative effects of six derivatives of oxy...
1 CitationsSource
#1Hongmei CuiH-Index: 1
#1Hongmei Cui (UTHSC: University of Tennessee Health Science Center)H-Index: 1
Last. Wei LiH-Index: 54
view all 4 authors...
Melanoma is one of the deadliest skin cancers having a five-year survival rate around 15-20%. An overactivated MAPK/AKT pathway is well-established in BRAF mutant melanoma. Vemurafenib (Vem) was the first FDA-approved BRAF inhibitor and gained great clinical success in treating late-stage melanoma. However, most patients develop acquired resistance to Vem within 6-9 months. Therefore, developing a new treatment strategy to overcome Vem-resistance is highly significant. Our previous study reporte...
Source
#1Chao Wang (SPU: Shenyang Pharmaceutical University)H-Index: 1
#2Yuelin Li (SPU: Shenyang Pharmaceutical University)
Last. Weige Zhang (SPU: Shenyang Pharmaceutical University)H-Index: 16
view all 12 authors...
A series of 1-aryl-5-(4-arylpiperazine-1-carbonyl)-1H-tetrazols as microtubule destabilizers were designed, synthesised and evaluated for anticancer activity. Based on bioisosterism, we introduced the tetrazole moiety containing the hydrogen-bond acceptors as B-ring of XRP44X analogues. The key intermediates ethyl 1-aryl-1H-tetrazole-5-carboxylates 10 can be simply and efficiently prepared via a microwave-assisted continuous operation process. Among the compounds synthesised, compound 6-31 showe...
1 CitationsSource
#1Gang Li (Southern Medical University)H-Index: 2
#2Yuxi Wang (Sichuan University)H-Index: 18
Last. Jianjun Chen (Southern Medical University)H-Index: 4
view all 10 authors...
Abstract A series of Pyrazolo[1,5-a]Pyrimidine analogues were designed and synthesized as novel tubulin inhibitors. Among them, compounds 1a and 1b showed the highest antiproliferative activity against a panel of cancer cell lines with average IC50 values of 24.8 nM and 28 nM, respectively. We determined the crystal structures of 1a and 1b in complex with tubulin and confirmed their direct binding to the colchicine site. Compounds 1a and 1b also effectively inhibited tubulin polymerization in vi...
9 CitationsSource